Immunophenotypic analysis of hematologic malignancy by laser scanning cytometry

American Journal of Clinical Pathology

Volumn 105, Issue 6, 1996, Pages 744-755

  Clatch, Richard J ^a   Walloch, Jami L ^a   Zutter, Mary M ^b   Kamentsky, Louis A ^c  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Compu Cyte Corporation ^*  (United States)

Author keywords

CD antigens; Flow cytometry; Immunophenotyping; Laser scanning cytometry (LSC)

Indexed keywords

ARTICLE; COMPUTER ASSISTED DIAGNOSIS; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LASER; LEUKEMIA; LYMPH NODE BIOPSY; LYMPHOMA; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PRIORITY JOURNAL;

EID: 0030000239     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.6.744     Document Type: Article

References (39)

1. Braylan RC. Lymphomas. In: Bauer KD, Duque RE, Shankey TV, eds. Clinical Flow Cytometry. Baltimore: Williams and Wilkins, 1993, pp 203-234.
2. Duque RE, Braylan RC. Applications of flow cytometry to diagnostic hematopathology. In: Coon JS, Weinstein RS, eds. Diagnostic Flow Cytometry. Baltimore: Williams and Wilkins, 1991, pp 89-102.
3. Duque RE. Acute leukemias. In: Bauer KD, Duque RE, Shankey TV, eds. Clinical Flow Cytometry. Baltimore: Williams and Wilkins, 1993, pp 235-245.
4. Knowles DM, Chadburn A, Inghirami G. Immunophenotypic markers useful in the diagnosis and classification of hematopoietic neoplasms. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore: Williams and Wilkins, 1992, pp 73-167.
5. Sun T. Color Atlas-Text of Flow Cytometric Analysis of Hematologic Neoplasms. New York: Igaku Shoin, 1993, pp 3-8 (Instrumentation), 18-25 (Classification of hematologic neoplasms), and 206-211 (Sample preparation).
6. Willman CL. Flow cytometric analysis of hematologic specimens. In: Knowles DM, ed. Neoplaslic Hematopathology. Baltimore: Williams and Wilkins, 1992, pp 169-195.
7. Braylan RC, Benson NA. Flow cytometric analysis of lymphomas. Arch Pathol Lab Med 1989;113:627-633.
8. Diamond LW, Nathwani BN, Rappaport H. Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer 1982;50:1122-1135.
9. Foon KA, Todd RF III. Immunologic classification of leukemia and lymphoma. Blood 1986;68:1-31.
10. Neam PB, Soamboonsrup P, Browman GP, et al. Classifying acute leukemia by immunophenotyping: A combined FAB-immunologic classification of AML. Blood 1986;68:1355-1362.
11. Picker LJ, Weiss LM, Medeiros LJ, et al. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 1987;128:181-201.
12. Sneige N, Dekmezian RH, Katz RL, et al. Morphologic and immunocytochemical evaluation of 220 fine-needle aspirates of malignant lymphoma and lymphoid hyperplasia. Acta Cytol 1990;34:311-322.
13. Sun T, Susin M. A practical approach to immunophenotyping of lymphomas: Comparison of immunohistologic and immunocytologic techniques. Ann Clin Lab Sci 1987;17:14-16.
14. Witzig TE, Banks PM, Stenson MJ, et al. Rapid immunotyping of B-cell non-Hodgkin's lymphomas by flow cytometry: A comparison with the standard frozen-section method. Am J Clin Pathol 1990;94:280-286.
15. Kamentsky LA, Kamentsky LD. Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data. Cytometry 1991;12:381-387.
16. Martin-Reay DG, Kamentsky LA, Weinberg DS, Hollister KA, Cibas ES. Evaluation of a new slide-based laser scanning cytometer for DNA analysis of tumors: Comparison with flow cytometry and image analysis. Am J Clin Pathol 1994;102:432-438.
17. Knowles DM. Organization and operation of a hematopathology laboratory. In: Knowles DM, ed. Neoplaslic Hematopathology. Baltimore: Williams and Wilkins, 1992, pp 323-366.
18. Knapp W, Dorken B, Gilks WR, Rieber EP, et al, eds. Appendix A: CD Guide Leukocyte Typing IV: White Cell Differentiation Antigens. New York: Oxford University Press, 1989, pp 1074-1093.
19. Almasri NM, Iturraspe JA, Benson NA, Chen MG, Braylan RC, Flow cytometric analysis of terminal deoxynucleolidyl transferase. Am J Clin Pathol 1991;95:376-380.
20. Syrjala MT, Tiirikainen M, Jansson S, Krusius T. Flow cytometric analysis of terminal deoxynucleotidyl transferase: A simplified method. Am J Clin Pathol 1993;99:298-303.
21. Falini B, Taylor CR. New developments in immunoperoxidase techniques and their application. Arch Pathol Lab Med 1983;107:105-117.
22. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981;75:816-821.
23. Tubbs RR, Sheibani K. Immunohistology of lymphoproliferative disorders. Semin Diag Pathol 1984;1:272-284.
24. Bennett JM, Catovsky D, Daniel MT, et al. French-American-British (FAB) Cooperative Group; Proposals for the classification of acute leukemias. Br J Haematol 1976;33:451-458.
25. Bennett JM, Catovsky DD, Flandrin G, et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985;103:626-629.
26. Bennett JM, Catovsky DD, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). Ann Intern Med 1985;103:460-462.
27. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112-2135.
28. First MIC Cooperative Study Group: Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Cancer Genet Cytogenet 1986;23:189-197.
29. Second MIC Cooperative Study Group. Morphologic, immunologic, and cytogenetic (MIC) working classification of acute myeloid leukemias. Br J Haematol 1988;68:487-494.
30. Bowman GP, Neame PB, and Soambonsrup P. The contribution of cytochemistry and immunophenotyping to the reproducibility of the FAB classification in acute leukemia. Blood 1986;68: 900-905.
31. Dick F, VanLier S, Banks P. Use of the working formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnoses and a panel of experienced patholagists. J Natl Cancer Inst 1987;78:1137-1144.
32. Head DR, Savage RA, Cerezo L, et al. Reproducibility of the French-American-British classification of acute leukemia: The Southwest Oncology group experience. Ann J Hematol 1985;18: 47-57.
33. Pitts WC, Weiss LM. The role of fine-needle aspiration biopsy in diagnosis and management of hematopoietic neoplasms. In: Knowles DM, ed. Neoplastic Hematopathology. Baltimore: Williams and Wilkins, 1992, pp 385-405.
34. Sheibani K, Nathwani BN, Swartz WG, et al. Variability in interpretation of immunohistologic findings in lymphoproliferative disorders by hematopathologists: A comprehensive statistical analysis of interobservor performance. Cancer 1988;62:657-664.
35. Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993;82:343-362.
36. Robbins BA, Ellison DJ, Spinosa JC, et al. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993;82:1277-1287.
37. Geisler CH, Larsen JK, Hansen NE, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991;78:1795-1802.
38. Ball ED, Davis RB, Griffin JD, et al. Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 1991;77: 2242-2250.
39. Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance. Blood 1995;85:1416-1434.